The FDA approved mFlusiva, the first mRNA-based influenza vaccine, for adults 50 years and older with accelerated approval for those 65 and older.

Health officials launched a nationwide trial to find out whether a drug used to treat diabetes can help veterans with alcohol use disorder.

Two Michigan residents have died in a widening outbreak of cyclosporiasis, the first deaths from this parasite ever confirmed in the US.

Women with long COVID experience higher neurologic symptom burden and worse fatigue than men, regardless of hospitalization status.

The 2024-2025 US influenza vaccine provided moderate protection against outpatient illness, reducing medically attended visits by one-third.

A retrospective study shows rising sepsis-related mortality in older adults with influenza or pneumonia, peaking in 2021.

Postoperative risks for sepsis and pulmonary embolism are highest when joint arthroplasty occurs within 4 weeks of COVID-19 diagnosis.

The FDA has accepted for Priority Review the New Drug Application for D-PLEX100 for the prevention of SSIs in patients undergoing surgery.

The FTC has sued telehealth company Hims & Hers, alleging it shared consumers' private health information with advertising platforms.

Many young adults may be entering adulthood without the skills needed to manage their own health care, according to a recent survey.

Disease-specific immune trajectories are identified years before onset of inflammatory bowel disease, according to results of a recent study.

Tenofovir alafenamide fumarate achieves viral suppression rates comparable to tenofovir disoproxil fumarate in patients with chronic hepatitis B virus infection, with an improved safety profile, ...